B. M. Chen

Antimicrobial peptide buforin I inhibits tissue factor-initiated coagulation.

H. Lin, A. Chu, B. M. Chen, 2001, Archives of biochemistry and biophysics.

Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug

J. Chern, T. Cheng, S. Roffler, 1999, British Journal of Cancer.

Cure of malignant ascites and generation of protective immunity by monoclonal antibody–targeted activation of a glucuronide prodrug in rats

J. Chern, S. Roffler, B. M. Chen, 1997, International journal of cancer.

Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates.

S. Roffler, B. M. Chen, M. Yeh, 1991, Cancer research.

Characterization of an antineoplastic glucuronide prodrug.

J. Chern, T. Cheng, S. Roffler, 1999, Biochemical pharmacology.

Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy.

S. Roffler, B. M. Chen, J. Y. Chen, 2000, Gynecologic oncology.

Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy.

J. Chern, T. Cheng, S. Roffler, 2000, Bioconjugate chemistry.